Evoke Pharma Inc. (NASDAQ:EVOK) changes shares on Monday trading session, with a change of 9.62% or $0.23 shares. The trading starts at $2.50 and closed at $2.39 throughout the day. The trading session low price was $2.43 and day high was $2.7699 on Monday, June 15. After the session, the Healthcare sector daily volume shifted to 2.02 million while its average volume is 442.74K. In other hand, the EVOK market cap reached to $59.87M. While, its current target price is $2.62 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 0.77% and up 85.82% for month. Its quarterly performance was 191.11% above, while its half year performance is up 63.75%. EVOK yearly performance stood at positive 309.38% and rise 61.73% for year-to-date. Current recommendation for Evoke Pharma Inc. is 3.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. EVOK EPS (TTM) for 12-month is -0.29. EPS for this year is 29.90%, while for the next year its value is -0.14. Its EPS Q/Q reached 34.80%. It has an EPS of 32.00% up for past five years and for the next five years will be up 40.00%.
Let’s take a look on the analyst recommendations on EVOK for the current month and previous month. For the current month, 0 of 1 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $9.00-$9.00. Average target price for EVOK was reached at $9.00.
Vanguard Group, Inc. (The), Michigan (State Of) Teachers Retirement System and Geode Capital Management, LLC are the top three holders in Evoke Pharma Inc. (EVOK) stock. On Mar 30, 2020, Vanguard Group, Inc. (The) has 0.48 million shares which valued 0.56 million. On Mar 30, 2020, Michigan (State Of) Teachers Retirement System owned 0.4 million shares which valued at 0.46 million. On Mar 30, 2020, Geode Capital Management, LLC has a total of 0.2 million shares which valued at 0.24 million. In the end, Geode Capital Management, LLC have 0.83% shares outstanding of Evoke Pharma Inc. (EVOK) on Mar 30, 2020. The insider ownership moved to 1.10% and institutional holding shifted to 14.60%.
The company posted an EPS (TTM) of -0.29. According to the most recent quarter report on (Jun 2020), 1 analysts estimated an average EPS of -0.06, while -0.09 EPS posted a year ago period. Analyst Estimated EPS for EVOK published in the report was -0.06–0.06 during the same period. Comparing with last year, the average estimated EPS was -0.09 which is lower than -0.07 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for EVOK rise 97.87% for period of 200 days. SMA for 50 days was 57.17% which is showing green signal, while SMA-20 was 15.04%. The moving average value for Evoke Pharma Inc. (EVOK) is 1.5077 and 1.9163 for 200 and 50 days respectively.